Literature DB >> 17353501

Risedronate for the prevention of hip fractures: concern about validity of trials.

Jutta Martha Halbekath, Stefanie Schenk, Andreas von Maxen, Gabriele Meyer, Ingrid Mühlhauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17353501     DOI： 10.1001/archinte.167.5.513-b

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  3 in total

1.  Check for publication integrity before misconduct.

Authors:  Andrew Grey; Mark J Bolland; Alison Avenell; Andrew A Klein; C K Gunsalus
Journal:  Nature       Date:  2020-01       Impact factor: 49.962

2.  Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.

Authors:  D Prieto-Alhambra; A Judge; N K Arden; C Cooper; K W Lyles; M K Javaid
Journal:  Osteoporos Int       Date:  2013-06-28       Impact factor: 4.507

3.  An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature.

Authors:  Alison Avenell; Fiona Stewart; Andrew Grey; Greg Gamble; Mark Bolland
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.